Loading market quotes…

Subscribe free
Wall Street Radar2 minFreeGBC Research

LUMO (Lumos Pharma,): stock research | Radar 4

Volume 4: Finding Gems in a Sea of Red

The market fell sharply, but some stocks held up better. This week’s watchlist focuses on that relative strength.


🎢 High-Volatility Thrill Rides 🎢

LUMO (Lumos Pharma, Inc.)

What they do: clinical-stage biopharmaceutical company focused on developing novel therapies for rare diseases

Why watch? Flagging under the critical $4 level. A breakout with volume could propel the stock to $4.5 and $5 as initial targets. Keep your eyes peeled for this potential rocket! 🧬🚀

LUMO (Lumos Pharma,): stock research | Radar 4 · figure 1

VTYX (Ventyx Biosciences, Inc.)

What they do: Clinical-stage biopharmaceutical company

Why watch? Recently broke out of a descending triangle and tested $2 support post-breakout. The 10 and 20 EMAs are providing additional support, setting up a bullish technical picture. 📊🧬

LUMO (Lumos Pharma,): stock research | Radar 4 · figure 2

OSTX (OS Therapies Incorporated)

What they do: Biotechnology company developing novel therapies for bone and soft tissue cancers

Why watch? This recent IPO is a fast-mover. A break of the current triangle formation could catapult the stock to all-time highs if market conditions align. Buckle up for potential volatility! 🔬📈

LUMO (Lumos Pharma,): stock research | Radar 4 · figure 3

🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️

BOX (Box, Inc.)

What they do: Cloud content management and file sharing service

Why watch? Stellar earnings at August-end showcasing relative strength. Currently forming a bullish pennant pattern. Traders can consider strategies targeting a break of $34 resistance or a bounce off $32 support. 📦💻

LUMO (Lumos Pharma,): stock research | Radar 4 · 🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️ · figure 4

NOAH (Noah Holdings Limited)

What they do: Wealth management service provider

Why watch? Impressive earnings candle on August 29, demonstrating remarkable strength amidst market weakness. A textbook triangle formation is primed for a potential breakout. 💰📈

LUMO (Lumos Pharma,): stock research | Radar 4 · 🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️ · figure 5

ARQT (Arcutis Biotherapeutics, Inc.)

What they do: Dermatology-focused biopharmaceutical company

Why watch? The $11 level represents a formidable resistance, tested multiple times without a convincing break. Currently flagging near this critical level, setting up for a potential breakthrough. 💊🔬

LUMO (Lumos Pharma,): stock research | Radar 4 · 🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️ · figure 6

SOC (Sable Offshore Corp)

What they do: Offshore drilling and oil exploration company

Why watch? A significant catalyst on September 3 was to revive their offshore unit in California. Consider a bounce play following the recent pullback. ⛽

LUMO (Lumos Pharma,): stock research | Radar 4 · 🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️ · figure 7

IMMR (Immersion Corporation)

What they do: Haptic technology development

Why watch? Triple-tested the $8.40 weekly level, a former resistance now turned strong support. A break above $8.80 could signal a bullish trend continuation. 🖱️💪

LUMO (Lumos Pharma,): stock research | Radar 4 · 🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️ · figure 8

🛡️ Low-Risk Safe Harbors 🛡️

SBUX (Starbucks Corporation)

What they do: Global coffee shop chain

Why watch? The crucial $90 level (also a gap level from August 13) is holding firm. The stock is flagging near this support, and a break to the upside could inject fresh momentum. Time for a caffeine boost? ☕

LUMO (Lumos Pharma,): stock research | Radar 4 · 🛡️ Low-Risk Safe Harbors 🛡️ · figure 9

VEEV (Veeva Systems Inc.)

What they do: Cloud-based software for the life sciences industry

Why watch? A bullish pennant formation is taking shape. The stock has shown resilience this week, potentially positioning itself as a future market leader. 🚀💊

LUMO (Lumos Pharma,): stock research | Radar 4 · 🛡️ Low-Risk Safe Harbors 🛡️ · figure 10
Newsletter

This piece was free. The next one lands on Sunday.

Every Sunday, we analyze up to ten stocks and publish our market view. A subscription includes the full research, price levels and our live positions in the chat. The free section arrives by email.

Related research
TOYO (Toyo Co.,): stock research | Radar 3Wall Street Radar · 02.09.2024BOF (BranchOut Food): stock research | Radar 5Wall Street Radar · 15.09.2024Brinker International (EAT) and trading patience | Radar 71Wall Street Radar · 25.01.2026Baidu (BIDU), tariffs and trade-war risk | Radar 70Wall Street Radar · 18.01.2026GRRR (Gorilla Technology): stock research | Radar 10Wall Street Radar · 13.10.2024 Full archive →
FREE · EVERY SUNDAY

Get the next Radar
before Monday’s open.

The first name, the reasoning, and our public research.

FREE · EVERY SUNDAYGet the watchlist